抗抑郁劑單藥與聯(lián)合用藥治療驚恐障礙的療效及衛(wèi)生經(jīng)濟(jì)學(xué)比較
[Abstract]:Objective: to compare the efficacy of antidepressant alone and atypical antipsychotics in the treatment of panic disorder and to provide reference basis for formulating reasonable treatment plan and reducing medical cost in the future. Methods: the clinical data of 98 patients with panic disorder diagnosed for the first time in hospital were retrospectively analyzed. There were 43 patients in the single antidepressant group and 55 in the combined group who were treated with atypical antipsychotics. Hamilton anxiety scale (HAMA),) and Hamilton Depression scale (HAMD) were used in both groups. The cure rate, effective rate, HAMA total score and each factor score, HAMD total score and each factor score, hospitalization days, hospitalization expenses and so on were compared between the two groups. Results: (1) the cure rate was 67.4 and the effective rate was 97.7in the single drug group, the cure rate was 63.6 in the combined group and the effective rate was 98.2. There was no significant difference between the two groups (P > 0.05). (2) there was no significant difference in the total score of HAMA, the score of somatization anxiety factor and the score of mental anxiety factor between the two groups after treatment (P > 0. 05). (3) there was significant difference in the scores of block factors between the two groups after treatment (P < 0.05). However, there was no significant difference in total HAMD score, anxiety / somatization factor score, body weight factor score, cognition disorder factor score, sleep disturbance factor score, despair factor score and systemic symptom factor score (P > 0. 05). (4) there was no significant difference in hospitalization days between the two groups (P > 0.05), but the cost of hospitalization in the combined group was higher than that in the single drug group (P < 0.05). Conclusion: the combination of atypical antipsychotics and single drug in the treatment of panic disorder has no significant difference in curative effect, and the hospitalization days of the patients are not reduced, but the hospitalization costs are increased.
【學(xué)位授予單位】:廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2012
【分類號(hào)】:R749.7
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王亞玲,王立新,馬振霞;驚恐障礙50例臨床觀察[J];張家口醫(yī)學(xué)院學(xué)報(bào);2004年02期
2 姜佐寧;驚恐障礙的現(xiàn)代治療[J];中華結(jié)核和呼吸雜志;2001年09期
3 喬愛萍;;驚恐障礙50例臨床觀察[J];實(shí)用醫(yī)技雜志;2005年19期
4 張培琰;驚恐障礙的表現(xiàn)及治療[J];中國(guó)處方藥;2004年07期
5 張獻(xiàn)共,鄭少雄;驚恐障礙的心理學(xué)研究[J];汕頭大學(xué)醫(yī)學(xué)院學(xué)報(bào);1998年01期
6 黃興兵,梅芳,張晉碚,關(guān)念紅,陶炯,王相蘭,魏欽令;驚恐障礙患者血兒茶酚胺和皮質(zhì)醇水平的研究[J];中國(guó)行為醫(yī)學(xué)科學(xué);2005年01期
7 陳景清,張麗,趙萬利,王年生;驚恐障礙30例臨床分析[J];四川精神衛(wèi)生;1994年04期
8 萬國(guó)斌;基層醫(yī)療中的驚恐障礙[J];國(guó)際精神病學(xué)雜志;1987年03期
9 周福初;SSRI治療驚恐障礙時(shí)發(fā)生抑郁[J];國(guó)外醫(yī)學(xué).精神病學(xué)分冊(cè);1994年03期
10 袁浩龍,張莉,趙玉山,戴永干,周蓓蓓,尹小紅;驚恐障礙患者血清膽固醇水平及與抗驚恐治療關(guān)系的研究[J];四川精神衛(wèi)生;1997年03期
相關(guān)會(huì)議論文 前10條
1 孔繁鑫;吳佳蘋;;驚恐障礙基礎(chǔ)及臨床研究進(jìn)展[A];中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)精神疾病專業(yè)委員會(huì)第十屆學(xué)術(shù)會(huì)議論文集[C];2010年
2 蔡利強(qiáng);王新玲;魏麗麗;章迎春;陳煒;陳婉珍;王偉;;驚恐障礙患者的面部情緒認(rèn)知[A];2011年浙江省心身醫(yī)學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2011年
3 陳貴珍;許云祥;王小云;;代謝組學(xué)技術(shù)在女性更年期驚恐障礙防治機(jī)制中的應(yīng)用思考[A];第十次全國(guó)中醫(yī)藥傳承創(chuàng)新與發(fā)展學(xué)術(shù)交流會(huì)暨第二屆全國(guó)中醫(yī)藥博士生優(yōu)秀論文頒獎(jiǎng)會(huì)議論文集[C];2011年
4 浦夢(mèng)佳;張志s
本文編號(hào):2348343
本文鏈接:http://sikaile.net/yixuelunwen/jsb/2348343.html